Medicare Enrolled

Dr. Stephen Mahoney, M.D.

Optician · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2925 BRIARPARK DR STE 250, Houston, TX 77042
2815583376
In practice since 2006 (19 years)
NPI: 1295743490 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mahoney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mahoney? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mahoney

Dr. Stephen Mahoney is an optician specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mahoney performed 5,397 Medicare services across 2,688 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mahoney received a total of $153,689 from 48 pharmaceutical and/or device companies across 1188 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mahoney is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 13% volume in TX $153,689 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,397
Medicare services
Top 13% in TX for optician
2,688
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~284 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 1,486 $5 $25
Office visit, established patient (20-29 min) 1,349 $66 $225
Destruction of precancerous skin growth, 1 554 $40 $175
Destruction of skin growths (warts/lesions), 1-14 370 $81 $275
Steroid injection (triamcinolone) 258 $1 $10
Office visit, established patient (30-39 min) 224 $93 $299
New patient office visit (30-44 min) 215 $71 $250
Application of ultraviolet light to skin 205 $19 $125
Drug injection, under skin or into muscle 158 $11 $45
Skin biopsy, tangential 112 $71 $275
Injection into skin growth, 1-7 growths 55 $34 $150
Office visit, established patient (10-19 min) 54 $41 $150
Destruction of precancer skin growth, 15 or more growths 42 $132 $375
Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm 37 $78 $375
Injection into skin growth, more than 7 growths 34 $50 $174
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm 29 $137 $450
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm 21 $139 $560
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm 20 $101 $400
New patient office visit (45-59 min) 20 $117 $400
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm 18 $140 $525
Punch biopsy, first skin growth 16 $103 $325
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm 16 $106 $375
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm 16 $125 $475
Shaving of skin growth of body, arms, or legs, 0.5 cm or less 14 $65 $325
Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm 14 $146 $475
Destruction of skin growth, 15 or more growths 13 $91 $350
All potassium hydroxide (koh) preparations 13 $6 $25
Acne surgery 12 $93 $325
Biopsy of related skin growth, each additional growth 11 $39 $139
Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm 11 $99 $375
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
11.9% medium
87.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$153,689
Total received (2018-2024)
Avg $21,956/year across 7 years
Top 3% in TX for optician
48
Companies
1,188
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$127,949 (83.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,467 (10.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,274 (6.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$15,870
2023
$12,380
2022
$11,217
2021
$13,463
2020
$16,007
2019
$54,246
2018
$30,505

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sun Pharmaceutical Industries Inc.
$32,686
Janssen Scientific Affairs, LLC
$30,166
AbbVie, Inc.
$27,732
Janssen Biotech, Inc.
$14,755
Novartis Pharmaceuticals Corporation
$7,102
Ortho Dermatologics, a division of Bausch Health US, LLC
$6,686
AbbVie Inc.
$6,047
SUN PHARMACEUTICAL INDUSTRIES INC.
$5,126
Dermavant Sciences, Inc.
$4,102
Incyte Corporation
$3,011
ABBVIE INC.
$2,472
MAYNE PHARMA INC.
$1,928
LEO Pharma Inc.
$1,883
Galderma Laboratories, L.P.
$1,473
Lilly USA, LLC
$1,232
UCB, Inc.
$971
Regeneron Healthcare Solutions, Inc.
$968
PFIZER INC.
$892
Amgen Inc.
$668
E.R. Squibb & Sons, L.L.C.
$640
Arcutis Biotherapeutics, Inc.
$585
GENZYME CORPORATION
$492
EPI Health, LLC
$291
NOVARTIS PHARMACEUTICALS CORPORATION
$250
REVANCE THERAPEUTICS, INC.
$249
Regeneron Pharmaceuticals, Inc.
$207
Merz North America, Inc.
$131
Celgene Corporation
$131
Ethicon US, LLC
$114
Almirall LLC
$109
STRATA Skin Sciences, Inc.
$91
SANOFI-AVENTIS U.S. LLC
$90
Taro Pharmaceuticals USA, Inc.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
Allergan Inc.
$42
Allergan, Inc.
$41
Genentech USA, Inc.
$28
Fresenius Kabi USA, LLC
$26
DERMIRA, INC.
$22
Tempus AI, Inc
$19
Medimetriks Pharmaceuticals, Inc.
$19
Helsinn Therapeutics (U.S.), Inc.
$18
Verrica Pharmaceuticals Inc.
$16
Sebela Pharmaceuticals Inc.
$15
MERZ NORTH AMERICA, INC.
$15
Journey Medical Corporation
$15
Solta Medical, a division of Bausch Health US, LLC
$15
Hill Dermaceuticals, Inc.
$13
Top 3 companies account for 58.9% of total payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · ARAZLO · Absorica LD · Aczone · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · DAXXIFY · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DermOtic · EBGLYSS · ECHELON FLEX Stapler · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · FABIOR · HALOG (Halcinonide Cream · HUMIRA · Humira · IDACIO · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · JUBLIA · Ketodan · Klisyri · Merlin Test · OPZELURA · ORACEA · Otezla · PRAMOSONE · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SORILUX · SPEVIGO · STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TWYNEO · Tremfya · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VALCHLOR · VTAMA · Veltin · Winlevi · XELJANZ · XEOMIN · XTRAC · Xeomin · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for optician in TX.

Equivalent to $2,848 per 100 Medicare services performed
Looking for an optician specialist in Houston?
Compare opticians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
508
Per 100K population
10.7
County median income
$73,104
Nearest hospital
ALTUS HOUSTON HOSPITAL, LP
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mahoney is a clinical cardiology specialist, with above-average Medicare volume (top 13% in TX), with speaking/promotional industry engagement in the top 3% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mahoney experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Mahoney performed 1,486 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mahoney receive payments from pharmaceutical companies?
Yes. Dr. Mahoney received a total of $153,689 from 48 companies across 1,188 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mahoney's costs compare to other opticians in Houston?
Dr. Mahoney's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mahoney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →